NOVARTIS AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 94.99 CHF | +0.52% |
|
+4.12% | +11.92% |
| Jun. 06 | AlphaValue/Baader Europe Lowers Price Target on Novartis, Maintains Add Recommendation | MT |
| Jun. 06 | Staff at drugmaker under U.S. scrutiny worked with Chinese military scientists | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 216B | ||||||
| 749B | ||||||
| 605B | ||||||
| 351B | ||||||
| 328B | ||||||
| 292B |
- Stock Market
- Equities
- NOVN Stock
- Charts Novartis AG
- Sector Chart
